Edition:
United States

ENDRA Life Sciences Inc (NDRA.OQ)

NDRA.OQ on NASDAQ Stock Exchange Capital Market

1.90USD
15 Feb 2019
Change (% chg)

$-0.06 (-3.06%)
Prev Close
$1.96
Open
$1.98
Day's High
$2.01
Day's Low
$1.87
Volume
14,367
Avg. Vol
75,583
52-wk High
$5.75
52-wk Low
$1.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.471
Mar '18 0.01 -0.720
FY 2017 Dec '17 0.01 -0.585
Sep '17 0.29 -0.233
Jun '17 0.06 -0.588
Mar '17 0.00 -0.190
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.11 35.99
P/E High - Last 5 Yrs. -- 132.66 51.07
P/E Low - Last 5 Yrs. -- 50.39 25.99
Beta -- 1.06 0.95
Price to Sales (TTM) 1,083.18 53.40 10.11
Price to Book (MRQ) -- 12.55 4.60
Price to Tangible Book (MRQ) -- 17.25 5.67
Price to Cash Flow (TTM) -- 62.05 26.60
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.59
Dividend Yield - 5 Year Avg -- 0.05 1.37
Dividend 5 Year Growth Rate -- 0.75 -7.66
Payout Ratio(TTM) -- 9.58 57.91

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 48.64 13.97
Sales (TTM) vs TTM 1 Yr. Ago -98.49 26.88 5.68
Sales - 5 Yr. Growth Rate -- 23.40 8.76
EPS (MRQ) vs Qtr. 1 Yr. Ago -201.90 8.83 1.73
EPS (TTM) vs TTM 1 Yr. Ago -106.71 -- --
EPS - 5 Yr. Growth Rate -- 19.09 8.38
Capital Spending - 5 Yr. Growth Rate -- 11.42 9.37

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.57 2.69 2.54
Current Ratio (MRQ) 0.57 3.52 3.50
LT Debt to Equity (MRQ) -- 15.82 13.45
Total Debt to Equity (MRQ) -- 29.82 16.95
Interest Coverage (TTM) -- 14.67 40.10

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 76.27 56.45 51.00
Gross Margin - 5 Yr. Avg. -- 63.45 52.41
EBITD Margin (TTM) -68,829.65 -- --
EBITD - 5 Yr. Avg -- 4.31 17.39
Operating Margin (TTM) -71,526.65 -284.48 -6.46
Operating Margin - 5 Yr. Avg. -- -12.07 12.33
Pre-Tax Margin (TTM) -74,695.01 -274.71 -5.56
Pre-Tax Margin - 5 Yr. Avg. -- -16.01 12.48
Net Profit Margin (TTM) -74,695.01 -281.73 -9.13
Net Profit Margin - 5 Yr. Avg. -- -21.54 8.76
Effective Tax Rate (TTM) -- 21.70 22.24
Effective Tax Rate - 5 Yr. Avg. -- 18.55 23.52

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,090,849 793,051,265
Net Income/Employee (TTM) -- 1,473,290 92,015,479
Receivable Turnover (TTM) -- 3.07 4.90
Inventory Turnover (TTM) 0.05 1.92 3.67
Asset Turnover (TTM) 0.00 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -221.74 8.02 10.19
Return on Assets - 5 Yr. Avg. -- 6.60 11.12
Return on Investment (TTM) -289.87 10.12 12.72
Return on Investment - 5 Yr. Avg. -- 8.66 14.32
Return on Equity (TTM) -289.87 10.40 13.73
Return on Equity - 5 Yr. Avg. -- 9.06 15.40
  1 Year 3 Year 5 Year
Sales % -31.80 -14.34 --
EPS (TTM) % -155.81 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ENDRA Life Sciences Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.15 -1.71 53 74
13 Week -54.55 -55.19 4 26
26 Week -29.51 -27.61 35 9
52 Week -45.25 -46.13 33 6
YTD 26.67 14.40 68 9
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.99%
# of Holders: 19
Total Shares Held: 1,557,685
3 Mo. Net Change: 826,325
# New Positions: 10
# Closed Positions: 3
# Increased Positions: 13
# Reduced Positions: 5
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.